Abiopharma

🔍 SAUNDERS BRENT L (Director)

Company: Bausch & Lomb Corp (BLCO)

Report Date: 2026-03-06

Detailed Transactions and Holdings:

• Acquired 14,700 shares of Common Shares, No Par Value at $17.14 per share (Direct)
  Date: 2026-03-06 | Code: P | equity_swap_involved: 0 | shares_owned_after: 966,575.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 14,700 shares of Common Shares, No Par Value (Direct)
  Date: 2026-03-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 981,275.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Reflects a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.09 to $17.19 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
• F2: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances).